Myocardial infarction (MI) still represents the "Number One Killer" in the world. The lack of functional vasculature of the infracted myocardium under
hypoxia is one of the main problems for cardiac repair. In this study, a thermosensitive
chitosan chloride-RoY (
CSCl-RoY)
hydrogel was developed to improve angiogenesis under
hypoxia after MI. First, RoY
peptides were conjugated onto the
CSCl chain via
amide linkages, and our data show that the conjugation of RoY
peptide to
CSCl does not interfere with the temperature sensitivity. Then, the effect of
CSCl-RoY
hydrogels on vascularization in vitro under
hypoxia was investigated using human umbilical vein endothelial cells (HUVECs). Results show that
CSCl-RoY
hydrogels can promote the survival, proliferation, migration and tube formation of HUVECs under
hypoxia compared with
CSCl hydrogel. Further investigations suggest that
CSCl-RoY
hydrogels can modulate the expression of membrane surface
GRP78 receptor of HUVECs under
hypoxia and then activate Akt and ERK1/2 signaling pathways related to cell survival/proliferation, thereby enhancing angiogenic activity of HUVECs under
hypoxia. To assess its therapeutic properties in vivo, a MI model was induced in rats by the left anterior descending artery
ligation.
CSCl or
CSCl-RoY
hydrogels were injected into the border of infracted hearts. The results demonstrate that the introduction of RoY
peptide can not only improve angiogenesis at MI region but also improve the cardiac functions. Overall, we conclude that the
CSCl-RoY may represent an ideal scaffold material for
injectable cardiac tissue engineering.